New York · 2025 Regular Session · Bill
A 3496: Relates to enhancing patient access to medication assisted treatment for treatment of opioid disease
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 3496 is a bill introduced in the New York House on January 28, 2025. According to its official title, it concerns: Relates to enhancing patient access to medication assisted treatment for treatment of opioid disease. Primary sponsor: John McDonald (Democratic). It lists 3 additional sponsors. Most recent recorded action (January 7, 2026): REFERRED TO HIGHER EDUCATION.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Allows a licensed pharmacist to prescribe and order FDA-approved medication assisted therapy under a non-patient-specific regimen for the treatment of opioid use disease.
Sponsors
Sponsors by party (alphabetical): Democratic 4
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| John McDonald | Primary sponsor | Democratic | House | 108 |
| Karen McMahon | Co-sponsor | Democratic | House | 146 |
| Phil Steck | Co-sponsor | Democratic | House | 110 |
| Al Stirpe | Co-sponsor | Democratic | House | 127 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HIGHER EDUCATION
- REFERRED TO HIGHER EDUCATION